Medical News

RSS

Five Research Units established to uncover physiological basis for cognitive processes, cultural techniques

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing five new Research Units. This was decided by the DFG Senate at its October meeting. The purpose of the research collaborations is to offer researchers the possibility to pursue current, pressing issues in their subject areas and to establish innovative work directions.

19 Oct 2013

New study guides clinicians and policy makers on cost-effectiveness of anticoagulant drugs

Patients who are responding below par to the anticoagulant drug warfarin have several options. They can undergo even more blood tests to monitor their response to the different dosages of this medication which is prescribed to prevent strokes, or they could start using one of the newer, yet more expensive, anticoagulants on the market.

19 Oct 2013

Dentist offers advanced teeth whitening options

Los Angeles tooth whitening dentist, Dr. Kevin Sands, offers advanced teeth whitening options to help patients erase many years' worth of stains from even the most discolored teeth.

19 Oct 2013

New book presents latest findings on reconstructive surgery of microtia/atresia of EAC

Remarkable progress in the development of new concepts and techniques used in reconstructive surgery of microtia/atresia of the external auditory canal (EAC) has been made since the beginning of the 21st century.

19 Oct 2013

Tech experts say total overhaul of healthcare.gov may be needed

Beyond consumers' problems using the federal website, insurers are getting flawed enrollment data from the few who manage to sign up for plans, the Wall Street Journal reports.

19 Oct 2013

RNA-based gene expression test potentially determine presence or absence of BRAF V600E mutation

Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced preliminary study results suggesting the potential for an RNA-based gene expression test to accurately detect the BRAF V600E gene mutation in thyroid nodule fine needle aspiration (FNA) samples.

19 Oct 2013

Viewpoints: Health marketplace already has eligibility verification; entitlement fight lies ahead

If I were an entrepreneur in Washington, I'd be racing to print a bunch of T-shirts that said, "My tea party Republican shut down the government, and all I got was this lousy income verification mandate."

19 Oct 2013

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults. ZORVOLEX was approved at dosage strengths that are 20 percent lower than currently available diclofenac products.

19 Oct 2013

HMS Holdings reports third quarter 2013 financial and operating results

HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report its third quarter 2013 financial and operating results at 8:00 a.m. Central/9:00 a.m. Eastern on Friday, November 8, 2013. Supplemental financial information including the press release and presentation will be available at http://investor.hms.com/events.cfm at approximately 7:30 a.m. Eastern on November 8.

19 Oct 2013

Unitedhealth says lower Medicare advantage payments forced smaller profit

The Minnetonka, Minn., company said government funding cuts to Medicare Advantage plans were one drag during the quarter, but it said overall medical costs remained in check (Terhune, 10/17).

19 Oct 2013

AMVI partners with ApolloMed to participate in Accountable Care Organization

Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), a physician-centric integrated healthcare delivery company, today announced that AMVI Medical Group ("AMVI") has contracted with ApolloMed ACO to participate in its Accountable Care Organization.

19 Oct 2013

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).

19 Oct 2013

As budget talks resume, parties may face tough decisions on Medicare, other entitlements

With the ink hardly dry on the deal providing short-term funding to reopen the government and to raise the debt ceiling, negotiators dived into the next round of fiscal talks. Media reports cast doubt on the possibility of a grand bargain, while Medpage Today suggests the latest deal muddled the prospects for an SGR fix.

19 Oct 2013

Luden partners with Thompson Square to celebrate "Voices Worth Hearing"

Luden's, the soothing throat drop loved by voices everywhere, today announced a new partnership with Thompson Square, the reigning Academy of Country Music and Country Music Association "Vocal Duo of the Year."

19 Oct 2013

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir). Levemir® FlexTouch® has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes).

19 Oct 2013

Thomson Reuters adds Cortellis Clinical Trials Intelligence for drug discovery and development

The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the addition of Clinical Trials Intelligence to the Thomson Reuters CortellisTM suite, the industry's most comprehensive information solution for drug discovery and development.

19 Oct 2013

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Each week, KHN compiles a selection of recently released health policy studies and briefs.

19 Oct 2013

Wnt5A signaling pathway helps researchers determine who may respond to BRAF inhibitors

One of the challenges of understanding cancer is trying to determine the mechanisms that drive metastasis, or the process by which tumor cells are able to spread throughout the body.

19 Oct 2013

OBHG ranks 5th place in size category in Best Places to Work in South Carolina Program

Ob Hospitalist Group (OBHG) has been ranked 5th in their size category in the Best Places to Work in South Carolina Program sponsored byThe South Carolina Chamber of Commerce, Best Companies Group and the publishers of SCBIZ News.

19 Oct 2013

Gallo Research Center issues grant to discover new medication to treat alcohol, substance abuse

The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants under its U.S. Army-funded research program intended to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.

19 Oct 2013

Medical News

Five Research Units established to uncover physiological basis for cognitive processes, cultural techniques

New study guides clinicians and policy makers on cost-effectiveness of anticoagulant drugs

Dentist offers advanced teeth whitening options

New book presents latest findings on reconstructive surgery of microtia/atresia of EAC

Tech experts say total overhaul of healthcare.gov may be needed

RNA-based gene expression test potentially determine presence or absence of BRAF V600E mutation

Viewpoints: Health marketplace already has eligibility verification; entitlement fight lies ahead

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

HMS Holdings reports third quarter 2013 financial and operating results

Unitedhealth says lower Medicare advantage payments forced smaller profit

AMVI partners with ApolloMed to participate in Accountable Care Organization

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

As budget talks resume, parties may face tough decisions on Medicare, other entitlements

Luden partners with Thompson Square to celebrate "Voices Worth Hearing"

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Thomson Reuters adds Cortellis Clinical Trials Intelligence for drug discovery and development

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Wnt5A signaling pathway helps researchers determine who may respond to BRAF inhibitors

OBHG ranks 5th place in size category in Best Places to Work in South Carolina Program

Gallo Research Center issues grant to discover new medication to treat alcohol, substance abuse

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News